T he peripheral blood of humans and animals contains a unique subgroup of large granular lymphocytes that are able to kill tumor cells expressing aberrant class I MHC molecules (1) (2) (3) . These cells were later found to reside within a population of leukocytes that express the surface molecule NKp46/CD335 (4). Although not all NKp46 + cells are cytolytic, these cells are commonly referred to as NK cells. NK cells are a heterogeneous group of cells. In addition to cytolytic potential (5, 6) , many surface molecules are also differentially expressed by subsets of NK cells in both mice (7) (8) (9) and humans (7, (10) (11) (12) (13) (14) (15) . For example, in mice, NK cells can be divided into CD11b + and CD11b 2 subsets (16) . The CD11b + subset can be further divided into CD27
2 and CD27 + subsets (8, 9) . Finally, the CD27 2 CD11b + subset can be divided into killer cell lectin-like receptor G1 (KLRG1) + and KLRG1 2 subsets (17) (18) (19) . However, all NK cells express the heterodimeric IL-15Rbg IL-15 receptor (20) . Variation in IL-15 signaling plays an important role in NK cell biology.
In one extreme where no signal is received, NK cells die within a few hours (21) . In another extreme, a sustained high-level signal leads to accumulation of large numbers of NK cells with impaired functions (22) . Additionally, when the IL-15 signal is reduced from its normal physiological level, CD27 2 NK cells fail to develop (23, 24) . Further reduction of the signal leads to the elimination of CD11b + NK cells (23) . Conversely, when the IL-15 signal is increased from its normal physiological level, the proportion of KLRG1 + NK cells increases (18, 21, 22, 25) . Human NK cell deficiency can be divided into two categories, namely classical and functional NK cell deficiency. Classical NK cell deficiency is a rare disorder characterized by the absence of NK cells. Functional NK cell deficiency is a much more common and diverse disorder, in which NK cells are present, but their cytolytic function is severely impaired (26) . The importance of cytolytic NK cells in human health is convincingly established by the fact that patients who have functional NK cell deficiency are highly susceptible to infections despite the presence of large numbers of NK cells (26) . It is not clear whether these patients are also susceptible to cancer development later in life because they die of herpesvirus infections at a young age, but there is little doubt that cytolytic NK cells can efficiently kill many types of cancer cells in humans (27, 28) . Furthermore, mice with NK cell deficiency have dramatically increased tumor metastasis and outgrowth (29) .
Shortly after the discovery of NK cells, it was realized that cytolytic activity of NK cells is significantly lower in aged than in young mice (2, (30) (31) (32) . Furthermore, unlike young mice, aged mice fail to increase NK cell activity after infection (30) (31) (32) (33) . It is well documented that much of the infection-induced increase in cytolytic activity of NK cells is due to increased production of type I IFN in young mice (34) (35) (36) (37) . However, injection of type I IFN had little effect on NK cell cytolytic activity in aged mice (32, 38) . Aging-related impairment in cytolytic function of human NK cells has been recognized for many years (2, (30) (31) (32) (39) (40) (41) (42) . In particular, despite the presence of large numbers of NK cells, cytolytic granules are poorly developed in NK cells from aged people in part because perforin expression is decreased dramatically with aging (41) . Whereas a large majority of the NK cells in the peripheral blood of young people expressed KLRG1, which is upregulated in cytolytic effector NK cells (43, 44) , very few of the NK cells in the peripheral blood of aged people expressed this marker (42) . In contrast, the total number of NK cells changed little with aging (41, 42) . Thus, in both mice and humans, aging is associated with functional NK cell deficiency. However, the mechanism for this is unknown.
In this study, we employed adoptive cell transfers to address this question and found that NK cells from aged mice proliferated and upregulated KLRG1 normally in response to pathogen-derived products when transferred to young mice, suggesting that NK cells in aged mice are not intrinsically defective. In contrast, NK cells from young mice failed to proliferate and upregulate KLRG1 in response to pathogen-derived products when transferred to aged mice, suggesting that the host environment is responsible for agingrelated NK cell deficiency. Finally, aging-related NK cell defects could not be reversed by increasing the production of inflammatory cytokines such as TNF-a, IL-12, and IFN-g. However, soluble IL-15/IL-15Ra complexes effectively reversed the aging-related functional NK cell deficiency.
Materials and Methods

Mice
Male C57BL/6 mice at 2-24 mo of age were obtained from the National Institute on Aging contract colony at Harlan Laboratories (Indianapolis, IN) or from The Jackson Laboratory (Bar Harbor, ME). Mice were individually identified by ear punches and maintained under specific pathogenfree conditions and provided food and water ad libitum. NK cell priming in vivo NK cells were primed by i.p. injection of either polyinosinic-polycytidylic acid [poly(I:C); InvivoGen, San Diego, CA] at 100 mg/mouse or LPS (Sigma-Aldrich, St. Louis, MO) at 10 mg/mouse in 0.5 ml PBS. Some mice were primed by injecting both poly(I:C) (50 mg/mouse) and LPS (10 mg/ mouse). In other mice, IL-10 signaling was blocked by i.p. injection of anti-CD210 (1B1.3A) (IL-10R-blocking Ab) at 0.5 mg/mouse (Bio X Cell, West Lebanon, NH) 1 d before priming by poly(I:C) and LPS. Control mice in these experiments were given rat IgG at 0.5 mg/mouse (SigmaAldrich). When NK cells were primed with IL-15/IL-15Ra complex, each 1 mg recombinant murine IL-15 (R&D Systems, Minneapolis, MN) was incubated with 6 mg recombinant murine IL-15Ra-human IgG1-Fc (R&D Systems) for 30 min in 200 ml PBS at 37˚C. The IL-15/IL-15Ra complex was injected i.p. at 100 ng IL-15 per mouse in 0.5 ml PBS.
NK cell adoptive transfer
Single-cell suspensions were prepared from freshly harvested spleens by mechanical dissociation. NK cells were enriched by depleting erythrocytes, T cells, B cells, and granulocytes using negative enrichment kits (Miltenyi Biotec, Auburn, CA). For CFSE labeling, cells were resuspended at a concentration of 10 7 cells/ml in PBS (Sigma-Aldrich). CFSE (Invitrogen, San Diego, CA) was added to the single-cell suspension at a final concentration of 2 mM and incubated for 10 min at 37˚C. After incubation, the cells were washed once with complete RPMI 1640 (Sigma-Aldrich) and once with PBS. The cells were then checked for viability and fluorescent labeling using a fluorescent microscope. Approximately one million viable cells were transferred i.v. into each congenic recipient mouse.
Bone marrow stem cell adoptive transfer
Bone marrow chimeras were established using a novel approach based on a recent discovery that allows the replacement of a significant proportion of endogenous hematopoietic stem cells (HSCs) by adoptively transferred congenic HSCs without the disruption caused by irradiation (45 In vivo NK cell cytolytic activity assay 
Flow cytometry
Single-cell suspensions were prepared from freshly harvested spleens, femurs, lung, and lymph nodes by mechanical dissociation as previously described (46) . Total cell yields were determined by standard hemocytometric counting. Approximately 1 million cells were stained with fluorochrome-labeled Abs in 2% FBS-PBS buffer after blocking with anti-CD16/ CD32. Stained cells were washed, fixed, acquired using a BD LSR II flow cytometer (equiped with four lasers and controled by FACSDiva software; BD Biosciences), and analyzed with FlowJo software (Tree Star). NK cells were identified by their expression of NK1.1, which strictly coexpresses with NKp36, in CD3
2
CD5
2
CD19
2 leukocytes (CD45 + ). For peripheral blood analysis, 20 ml blood was collected via a tail vein nick. After lysing RBCs, the entire samples were stained and subjected to flow cytometric analysis. The number of NK cells per microliter was calculated from the total number of NK cells recorded in the sample. mAbs were purchased from BD Pharmingen (San Diego, CA), Serotec (Raleigh, NC), or eBioscience (San Diego, CA), including eFluor 450-, allophycocyanin-, allophycocyanin-Cy7-, Alexa Fluor 700-, PerCP-Cy5.5-, FITC-, PE-, PE-Cy7-, and PE-Cy5-conjugated anti-CD3 (145-2C11), anti- 
Statistical analysis
Single-factor ANOVA was used for intergroup comparisons with p , 0.05 considered to indicate significance.
blood at various time points after challenge. The blood was examined because it has been shown that cytolytic NK cells reside preferentially in peripheral blood, whereas nonlytic NK cells reside preferentially in secondary lymphoid organs (5, 47) . We found that in young mice, the number of NK cells in the blood increased dramatically after priming with LPS, reaching a peak leave 3-4 d after the challenge. In contrast, the number of NK cells in aged mice remained largely unchanged during a 6-d period after the challenge (Fig. 1A, 1B) . In addition to population expansion, priming of NK cells also leads to upregulation of KLRG1 expression, which is associated with cytolytic effector cell development (43, 44) . We found that the development of KLRG1 + NK cells after LPS challenge was severely impaired in aged mice (Fig. 1A, 1B) . Additionally, the baseline number of KLRG1 + NK cells was lower in aged mice than in young mice before the challenge. Similar aging-related defects were also demonstrable after mice were challenged with the TLR3 ligand poly(I:C) (Figs. 1C, 2D ). Although poly(I:C) was able to induce KLRG1 upregulation by day 6 in aged mice (Fig. 1C) , population expansion was still impaired. These data suggested that impaired NK cell expansion and activation may be responsible for aging-related functional NK cell deficiency.
NK cells from aged mice proliferate and upregulate KLRG1 normally in young mice in response to pathogen-derived products
We previously reported that NK cells from aged mice do not have intrinsic defects in their ability to produce IFN-g in response to pathogen-derived products. Rather, the host environment was responsible for the aging-related defect in IFN-g production (49, 50) . To determine whether NK cells in aged mice are intrinsically defective in response to priming, we cotransferred young CD45.1 + and aged CD45.2 + CFSE-labeled NK cells to young recipients, which were then challenged with both LPS and poly(I:C). It was found that transferred CFSE-labeled NK cells in blood and spleens from young and aged mice divided extensively and upregulated KLRG1 3 d after priming in young hosts (Fig. 2B, 2C ). Aged donor NK cells divided to the same degree as young donor NK cells, as indicated by the level of the mean fluorescence intensity (MFI) of CFSE labeling of the donor NK cells (Fig. 2D) . Although the proportion of KLRG1 + cells in aged donor NK cells was slightly lower than that in young donor NK cells 3 d after priming (Fig. 2D) , it was unlikely owing to an impaired response by aged donor NK cells but rather reflected the fact that the proportion of pretransfer KLRG1 + cells in aged donor NK cells was lower than that in young donor NK cells ( Fig. 2A) . These data suggest that NK cells in aged mice are not intrinsically defective in their ability to proliferate and differentiate in response to priming.
NK cells from young mice fail to proliferate and upregulate KLRG1 in aged mice in response to pathogen-derived products
To determine whether the aged host environment was responsible for the failure of NK cell expansion and activation after priming in aged mice, we transferred CFSE-labeled congenic CD45.1 + NK cells from young mice to either young or aged CD45.2 + recipients and analyzed the response of donor NK cells to priming by LPS and poly(I:C). As expected, NK cells from young mice divided extensively and upregulated KLRG1 3 d after priming in young hosts (Fig. 3B, 3C ). Although donor NK cells continued to divide after day 3, as indicated by the decrease of the MFI of CFSE labeling of the donor NK cells, the absolute number of donor NK cells decreased rather than increased from day 3 to day 6 after priming in young mice, suggesting that many primed NK cells are short-lived (Fig. 3B, 3C ). In contrast, fewer young donor NK cells proliferated 3 d after priming in aged recipients (15.6% in old versus 51.8% in young). Although the proportion of the dividing donor NK cells did increase by 6 d after priming in aged hosts, the MFI of CFSE labeling of donor NK cells was significantly higher in aged than in young hosts at both time points, indicating that donor NK cells divided less extensively in the aged environment (Fig. 3B, 3C) . As a result, the expansion of donor NK cells was significantly lower in aged than in young recipient mice (Fig. 3C) . Although the absolute number of donor NK cells in young recipient mice was significantly higher than in aged recipient mice (Fig. 3C) , the percentage of donor NK cells among all NK cells (host and donor) in young recipients was much lower than in aged recipients (Fig. 3B) because host NK cells of the young recipients expanded more than did those of the aged host recipients, as demonstrated in Fig. 1 . In addition to impaired expansion, upregulation of KLRG1 expression by young donor NK cells was also significantly impaired in aged as compared with young hosts (Fig. 3B, 3C ). Impaired expansion of and KLRG1 upregulation among donor NK cells in peripheral blood were not a result of altered tissue distribution because the same aging-related impairment was also observed in the recipient livers and spleens (Fig. 3D, 3E ). These data suggested that the host environment was responsible for aging-related defects in NK cell priming by pathogen-derived products.
Blockade of IL-10 signaling failed to reverse aging-related defects in NK cell priming by pathogen-derived products
We previously reported that aging is associated with increased production of IL-10 by macrophages in response to pathogenderived products in vivo (49, 50) . Additionally, blockade of IL-10 signaling by an anti-CD210 (IL-10 receptor) Ab dramatically increased the level of a wide range of cytokines and chemokines, including dendritic cell (DC)-derived IL-12 in aged mice, which in turn reversed the aging-related defect in IFN-g production by NK cells (49, 50) . To determine whether increased IL-10 production was also responsible for aging-related defects in NK cell priming, we blocked IL-10 signaling by injecting anti-CD210 in aged mice, which were then challenged with LPS and poly(I:C). As shown in Fig. 4 , blockade of IL-10 signaling in aged mice had no significant effect on NK cell expansion and KLRG1 upregulation. Additionally, injection of recombinant IFN-g, IL-12, and IL-18 individually or in combination failed to reverse agingrelated defects in NK cell priming by LPS (data not shown). These data suggest that unlike aging-related defects in IFN-g production by NK cells, aging-related defects in NK cell priming is not a result of impaired production of the cytokines due to age-related increases in IL-10 production by macrophages.
NK cell maturation is impaired in aged mice
NK cells in naive mice are phenotypically diverse and can be divided into CD27
2 and CD27 + subsets (8, 9, 16 Fig. 5 ). The effect of aging on NK cell maturation in naive mice can be easily detected using flow cytometry (51). For example, aging is associated with a shift from CD27 2 to CD27 + in NK cells in peripheral blood, lymph node, bone marrow, lung, and spleen (Fig. 5) . To better define the levels of population shift, the following formula was used to calculate the percentage shift in CD27 2/+ NK population with aging: percent shift = (1 2 R aged /R young ) 3 100, where R indicates the number of CD27 2 NK cells/the number of CD27 + NK cells. As shown in Fig. 5B , in all the organs tested, an ∼50% shift was found when mice were aged from 4 to 20 mo of age. These data suggest that NK cells in aged mice are intrinsically defective due to a maturation defect. However, studies have shown that CD27 + to CD27 2 NK cell maturation is regulated by IL-15 presentation (23, 24). In particular, the level of IL-15 presentation required for the acquisition of the CD27 2 phenotype is higher than the level required for the development of CD27 + NK cells (23) . Thus, when IL-15 presentation by macrophages or DCs is reduced, the maturation of NK cells appears to be arrested at the CD27 + stage (23, 24) . Therefore, the host environment could also be responsible for aging-related maturation defect in NK cell development. Bone marrow from aged mice gives rise to CD27 2 
NK cells normally in young hosts
To determine whether the host environment is responsible for NK cell maturation, we first tested whether the aging-related impairment in NK cell development is a result of a defect in bone marrow stem cells by cotransferring bone marrow cells from CD45. recipients. As shown in Fig. 6 , transferred bone marrow, which contains very few CD27-mature NK cells (Fig. 5) , gave rise to mature CD27 2 NK cells as early as 3 wk after transfer and continued to do so for at least 3 mo (Fig. 6A) . Importantly, the proportion of CD27 2 cells in NK cells that were derived from aged bone marrow was not significantly different from the proportion of CD27 2 cells in NK cells that were derived from young bone marrow (Fig. 6B ). These data suggest that aged immature NK cells and bone marrow HSCs are not intrinsically defective in their ability to give rise to mature CD27 2 NK cells.
Bone marrow stem cells from young mice fail to reverse the aging-related defect in NK cell maturation
To determine whether the host environment is responsible for aging-related defects in NK cell maturation, we transferred lineagedepleted bone marrow cells from young mice to aged mice. Bone marrow transfer is traditionally done only in irradiated recipients. However, for our purposes, whole body irradiation had to be avoided because it disrupts the host environment we were investigating.
Previous studies show that only ∼0.1% of the HSC niche is accessible via the blood under steady-state conditions (52) . Consistent with these data, our attempts to engraft HSCs in nonirradiated recipients failed as judged by the fact that no donor-derived leukocytes were generated regardless of how many stem cells were transferred (data not shown). Recently, it was reported that the HSC niche space could be made transiently accessible after injecting an anti-CD117 mAb. The space remained accessible for a few days after the Ab was cleared from the system, providing a brief time window for engrafting donor HSCs (45) . Using this approach, we were able to consistently engraft HSCs from CD45. (Fig. 7A) .
The maturation defect of the donor-derived NK cells remained unchanged during a 3-mo period and was observed not only in peripheral blood but also in the spleen and bone marrow (Fig. 7B ).
To better define the levels of phenotypic correction by young HSCs, the following formula was used to calculate the percentage correction of the aging-related CD27 2/+ NK population shift by young donor HSCs: percentage shift = (1 2 R donor /R host ) 3 100, where R indicates the number of CD27 2 NK cells/the number of Fig. 7C , no consistent correction by young HSCs was observed. These data indicated that the host environment rather than bone marrow stem cell defects are responsible for impaired, aging-related NK cell maturation.
NK cells in aged mice expand and upregulate KLRG1 normally in response to IL-15/IL-15Ra stimulation
Based on the current understanding of NK cell maturation, it is likely that the aging-related defect in CD27 + to CD27 2 NK cell transition (Figs. 5-7 ) is a result of impaired IL-15 presentation (23, 24) . Recently, it has also become clear that NK cell priming is mediated by macrophages and DCs in an IL-15-dependent manner (5, 6, 34, 48, (53) (54) (55) (56) (57) (58) . Interaction between IL-15-presenting macrophages/DCs and NK cells is responsible not only for NK cell proliferation but also for upregulation of granzyme B and perforin in nonlytic NK cells during NK cell priming (5, 6, 53, 59) . Interestingly, NK cell priming by IL-15 signaling appears to be independent of cellular context because NK cells can be primed effectively by the soluble IL-15/IL-15Ra complex (22, 60) . When NK cells from aged mice are not intrinsically defective, they should be primed by the IL-15/IL-15Ra complex. To test this, we injected the recombinant IL-15/IL-15Ra complex in young and aged mice. In contrast to pathogen-derived products (Fig. 1) , the IL-15/IL-15Ra complex expanded NK cells to the same degree in young and aged mice (Fig. 8) . Additionally, the complex also upregulated KLRG1 expression by NK cells similarly in young and aged mice (Fig. 8A ). These data demonstrated that agingrelated defects in NK cell maturation/priming can be reversed by IL-15 receptor agonists.
Priming of NK cells by the IL-15/IL-15Ra complex reverses aging-related functional NK cell deficiency
To determine whether the IL-15/IL-15Ra complex can also successfully prime NK cell cytolytic activity in aged mice, we first enumerated the number of granzyme B-expressing NK cells in naive and IL-15/IL-15Ra complex-injected young and aged mice. It was found that granzyme B is strictly coexpressed with KLRG1 by NK cells in peripheral blood of both young and aged mice, supporting the use of KLRG1 as a marker of cytolytic NK cells (Fig. 9A, 9B) . Furthermore, the number of granzyme B and KLRG1 double-positive NK cells was significantly higher in naive young mice than naive aged mice (Fig. 9C) . Injection of the IL-15/ IL-15Ra complex dramatically increased the number of these double-positive NK cells in both young and aged mice (Fig. 9C) . Finally, we measured NK cell cytolytic functional activity in vivo in these mice. NK cell-susceptible target cells from the spleens of H2K/D double-KO mice were injected i.v. into naive and IL-15/ IL-15Ra complex-primed young and aged mice along with control NK cell-resistant cells from the spleens of syngeneic WT mice. Specific percentage target killing of H2K/D KO cells was calculated by using the following formula: (1 2 R in /R out ) 3 100, where R in and Rout are the ratio of the number of KO/WT injected and recovered cells, respectively. Consistent with previous reports (5, 34, 48), we found that without priming, NK cell cytolytic activity in young mice was quite low (Fig. 9C) . However, unprimed naive young cells showed higher baseline cytotoxicity than did naive aged NK cells (Fig. 9C) . The cytolytic activity in both young and aged mice increased dramatically 3 d after IL-15 injection (Fig.  9C) . Thus, the functional assay precisely paralleled the phenotypic analysis (Fig. 9C) . These data demonstrated that aging-related functional NK cell deficiency can be reversed by administration of IL-15 receptor agonists. Recent transcriptome-wide analysis showed that priming affects a large number of genes in NK cells (44) . Upregulation of KLRG1, CD11b, and CD90 protein was also detected by flow cytometry (44) . Additionally, we have found that although CD27 is downregulated during NK cell maturation, it is transiently upregulated after priming (data not shown). To further characterize the effect of IL-15/IL-15Ra on NK cells in aged mice, we compared the expression levels of these molecules by NK cells in young and aged mice after injection of the IL-15/IL-15Ra complex. We first used a single marker that divides NK cells into two subpopulations (Fig. 10A) . It was found that the proportion of NK cell subpopulations defined by CD11b, CD27, or CD90 in aged mice was not significantly different from that in young mice 3 d after injection of the IL-15/IL-15Ra complex (Fig. 10A, 10B ). The proportion of NK cell subpopulations defined by KLRG1 in aged mice was also not significantly different from that in young mice 3 d after injection of the IL-15/IL-15Ra complex (Figs. 8. 9 ). We next used a combination of two markers that divides NK cells into four subpopulations (Fig. 10C) . For these experiments, we focused on CD27, CD90, and KLRG1. CD11b was not included because only a small minority of NK cells are CD11b 2 (Fig. 10A) . Again, the proportion of the subpopulations defined by these markers in aged mice was not significantly different from that in young mice 3 d after injection of the IL-15/IL-15Ra complex (Fig. 10C, 10D ). The proportion of subpopulations that were defined by using a combination of three markers (CD27, CD90, and KLRG1), which divides NK cells into eight subpopulations, in aged mice was also not significantly different from that in young mice 3 d after injection of the IL-15/IL-15Ra complex (data not shown). Taken together, these data suggest that NK cells in aged mice are activated similarly as those in young mice in response to IL-15 receptor agonists.
Discussion
Although aging-related functional NK cell deficiency is well documented (2, (30) (31) (32) (33) (34) (35) (36) (37) (39) (40) (41) (42) , the mechanism is poorly understood. By transferring NK cells from young to aged mice or vise versa, we demonstrated that the aged host environment rather than an intrinsic NK cell defect is responsible for aging-related defects in NK cell priming by pathogen-derived products. It has long been known that steady-state NK cells in aged animals and humans are phenotypically different from those in their younger counterparts. However, the mechanism for these observations has not been reported. By transferring bone marrow stem cells from young to aged mice or vise versa, we demonstrated that the host environ- ment rather than stem cells are responsible for aging-related defects in NK cell maturation under steady-state conditions. Furthermore, we showed that aging-related functional NK cell deficiency can be completely reversed by injecting soluble IL-15/IL-15Ra complexes. In contrast, blockade of IL-10 signaling, which broadly augments inflammatory responses to pathogen-derived products, has little effect on aging-related defects in NK cell priming. Our data thus demonstrate that the aged host environment is primarily responsible for aging-related functional NK cell deficiency.
Although the exact nature of the host factors responsible for aging-related functional NK cell deficiency remains to be defined, our data suggest that insufficient access to IL-15 presentation by NK cells and their precursors is responsible for aging-related functional NK cell deficiency. Both NK cell maturation (21, (61) (62) (63) and priming (54) (55) (56) (57) (58) are dependent on IL-15 presentation, and both are impaired in aging mice. It was surprising that blockade of IL-10, which broadly enhances inflammatory responses, had no effect on NK cell priming after LPS and poly(I:C) challenge of aged mice, whereas soluble recombinant IL-15/IL-15Ra alone completely reversed the aging-related functional NK cell deficiency. These data suggest that IL-15 presentation plays a dominant role in NK cell priming. Without sufficient IL-15 stimulation, other inflammatory cytokines such as IL-12 and IFN-g appear to contribute little to NK cell priming.
The biological activity of IL-15 is mediated by the heterodimeric IL-15 receptor, IL-15Rbg (64) . In IL-15-producing cells, IL-15 and its high-affinity IL-15 receptor, IL-15Ra, are preassembled before being presented on the cell surface or released from the cell (65) . Because bioactive IL-15 is presented on cell surface (24, (65) (66) (67) , access to IL-15 presentation by NK cells depends not only on the production and consumption of IL-15 but also on successful recruitment of NK cells by IL-15-presenting cells, which in turn depends on the production and consumption of NK cell-recruiting factors by IL-15-presenting cells. Unfortunately, as reported by others (36), the level of IL-15 presentation was too low to be reliably quantified with currently available reagents (B. Chiu, unpublished observations). Therefore, it remains unclear whether aging alters levels of IL-15 presentation by the various subsets of mononuclear phagocytes. This question can be addressed once aged IL-15 reporter mice become available (36) . Currently, the factors mediating NK cell recruitment by IL-15-presenting cells are poorly understood and the effect of aging is completely unknown. However, other aging-related defects in macrophages have been documented (49, 50, (68) (69) (70) . In addition to decreased production, increased competition for IL-15 and NK cell-recruiting factors may be responsible for insufficient access to IL-15 by NK cells and their precursors (14) . In young mice, NK cells represent the largest cell population that expresses the heterodimeric IL15Rbg IL-15 receptor. In contrast, in aged mice, memory phenotype CD8 T cells become the dominant population expressing this receptor (B. Chiu, unpublished observations). The potential role of competing memory phenotype CD8 T cells in contributing to the aging-related NK cell deficiency is currently under investigation.
Studies of cytolytic activities of human NK cells rely heavily on the radioactive in vitro chromium-release assay (71) . With this assay, a low level of "spontaneous" cytolytic activity can be detected in peripheral blood of normal donors (1) . Such in vitro NK cell activity is known to be amplified by IL-2, being many fold higher in the presence of IL-2 (72). Data regarding whether aging impairs spontaneous NK cell function are sometimes contradictory (73) . The low level of spontaneous cytolytic activity combined with high sensitivity to in vitro manipulation may explain conflicting results. Although IL-2 is commonly used to prime NK cells, the vast majority of NK cells express the heterodimeric IL15Rbg IL-15 receptor, which is also known as intermediate affinity IL-2 receptor (64), but not the high-affinity IL-2 receptor IL2Rabg (64, 74) . These data suggest that human NK cell priming by IL-2 in vitro is actually being mediated via the IL-15 receptor. Furthermore, in contrast to IL-2, which is produced transiently by recently activated T cells in secondary lymphoid tissues, IL-15 is produced constitutively in a wide variety of tissues (75) . Thus, in vivo, the heterodimeric IL-15Rbg IL-15 receptor is activated primarily by IL-15, not by IL-2. Although it is not yet clear whether the host environment is responsible for aging-related functional NK cell deficiency in humans, studies have shown that NK cells from aged humans can be successfully primed by IL-2 in vitro (41, 76) . Additionally, recent studies using humanized mouse models suggest that IL-15 presentation plays a similar role in human NK cell development and maturation as in mouse NK cell development and maturation. Thus, current data appear to be consistent with the hypothesis that insufficient access to IL-15 presentation by NK cells is likely responsible for aging-related functional NK cell deficiency in humans.
In summary, our study significantly advances our understanding of the effect of aging on NK cell function by providing novel evidence that the host environment is responsible for aging-related functional NK cell deficiency. Additionally, our data suggest that IL-15 receptor agonists may be useful tools in treating agingrelated functional NK cell deficiency, which may contribute to the impaired viral and tumor immunity.
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